Perioperative antibiotic regimen in rats treated with pamidronate plus dexamethasone and subjected to dental extraction: A study of the changes in the jaws

Journal of Oral and Maxillofacial Surgery

Volumn 69, Issue 10, 2011, Pages 2488-2493

  López Jornet, Pía ^a   Camacho Alonso, Fabio ^a   Martínez Canovas, Ascensión ^a   Molina Miano, Francisco ^a   Gómez García, Francisco ^a   Vicente Ortega, Vicente ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; PAMIDRONIC ACID; PENICILLIN G; PENILEVEL RETARD; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; JAW OSTEONECROSIS; MALE; MOLAR TOOTH; NONHUMAN; PEROPERATIVE CARE; PROSPECTIVE STUDY; RANDOMIZATION; RAT; TOOTH EXTRACTION; TREATMENT DURATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BONE DENSITY CONSERVATION AGENTS; DEXAMETHASONE; DIPHOSPHONATES; GLUCOCORTICOIDS; JAW DISEASES; MALE; OSTEONECROSIS; PENICILLIN G; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TOOTH EXTRACTION;

EID: 80053053394     PISSN: 02782391     EISSN: 15315053     Source Type: Journal    
DOI: 10.1016/j.joms.2011.02.059     Document Type: Article

References (31)

1. M. Aapro, P.A. Abrahamsson, and J.J. Body Guidance on the use of bisphosphonates in solid tumours: Recommendations of an international expert panel Ann Oncol 19 2008 420
2. M.R. McClung Bisphosphonates Endocrinol Metab Clin North Am 32 2003 3253
3. I.R. Reid Osteonecrosis of the jaw Who gets it and why? Bone 44 2009 4
4. D. Santini, U. Vespasiani-Gentilucci, and B. Vincenzi The antineoplastic role of bisphosphonates: From basic research to clinical evidence Ann Oncol 14 2003 1468
5. G. Slobodin, I. Rosner, and J. Feld Pamidronate treatment in rheumatology practice: A comprehensive review Clin Rheumatol 28 2009 1359
6. J. Wood, K. Bonjean, and S. Ruetz Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid J Pharmacol Exp Ther 302 2002 1055
7. M.A. Dimopoulos, E. Kastritis, and C. Bamia Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid Ann Oncol 20 2009 117
8. T. Boonyapakorn, I. Schirmer, and P.A. Reichart Bisphosphonate-induced osteonecrosis of the jaws: Prospective study of 80 patients with multiple myeloma and other malignancies Oral Oncol 44 2008 857
9. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic J Oral Maxillofac Surg 61 2003 1115
10. J.V. Bagan, C. Scully, and V. Sabater Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update Oral Oncol 45 2009 551
11. J.V. Bagan, J. Murillo, and Y. Jimenez Avascular jaw osteonecrosis in association with cancer chemotherapy: Series of 10 cases J Oral Pathol Med 34 2005 120
12. C.A. Migliorati Bisphosphonates and oral cavity avascular bone necrosis J Clin Oncol 21 2003 4253
13. M.C. Farrugia, D.-J. Summerlin, and E. Krowiak Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates Laryngoscope 116 2006 115
14. A. Wutzl, E. Biedermann, and F. Wanschitz Treatment results of bisphosphonate-related osteonecrosis of the jaws Head Neck 30 2008 1224
15. A. Bamias, E. Kastritis, and C. Bamia Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors J Clin Oncol 34 2005 8580
16. E.P. Wang, L.B. Kaban, and G.J. Strewler Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy J Oral Maxillofac Surg 65 2007 1328
17. A. Hoff, B.B. Toth, and K. Altundag Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates J Bone Miner Res 23 2008 826
18. M.H. Abu-Id, P.H. Warnke, and J. Gottschalk "Bis-phossy jaws"High and low risk factors for bisphosphonate-induced osteonecrosis of the jaw J Craniomaxillofac Surg 36 2008 95
19. S.L. Ruggiero, B. Thomas, and T.B. Dodson American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws2009 Update J Oral Maxillofac Surg 67 2009 2
20. S.L. Ruggiero, B. Mehrotra, and T.J. Rosenberg Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases J Oral Maxillofac Surg 62 2004 527
21. M.R. Allen, and D.B. Burr Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment J Oral Maxillofac Surg 66 2008 987
22. S.T. Sonis, B.A. Watkins, and G.D. Lyng Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients Oral Oncol 45 2009 164
23. F.C. Senel, M.K. Duman, and E. Muci Jaw bone changes in rats after treatment with zoledronate and pamidronate Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109 2010 385
24. D.B. Burr, and M.R. Allen Mandibular necrosis in beagle dogs treated with bisphosphonates Orthod Craniofac Res 12 2009 221
25. M.D. Melo, and G. Obeid Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy J Can Dent Assoc 71 2005 11
26. T. Hansen, M. Kunkel, and E. Springer Actinomycosis of the jawsHistopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis Virchows Arch 451 2007 1009
27. G.S. Wilkinson, Y.F. Kuo, and J.L. Freeman Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: A population-based analysis J Natl Cancer Inst 99 2007 1016
28. V. Montefusco, F. Gay, and F. Spina Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates Leuk Lymphoma 49 2008 2156
29. C.I. Ripamonti, M. Maniezzo, and T. Campa Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates The experience of the National Cancer Institute of Milan Ann Oncol 20 2009 137
30. M. Kos, and K. Luczak Bisphosphonates promote jaw osteonecrosis through facilitating bacterial colonisation Biosci Hypotheses 2 2009 34
31. G.N. Belibasakis, N. Bostanci, and A. Hashim Regulation of RANKL and OPG gene expression in human gingival fibroblasts and periodontal ligament cells by Porphyromonas gingivalis: A putative role of the Arg-gingipains Microb Pathog 43 2007 46